Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
11 May 2017 NICE Issues Technology Appraisal Guidance for Pegylated Liposomal Irinotecan Gastrointestinal cancers - Anticancer agents & Biologic therapy
10 May 2017 FDA Grants Accelerated Approval to Avelumab for Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
04 May 2017 IMPAKT 2017: High Baseline TIL Levels Signal Superior Responses in HER2-Positive Breast Cancer Breast cancer
04 May 2017 IMPAKT 2017: Luminal Androgen Receptor (LAR) Subtype of Triple Negative Breast Cancer (TNBC) Demonstrates In Vitro and In Vivo Sensitivity to CDK4/6 Inhibition Breast cancer - Translational research - Basic science
04 May 2017 IMPAKT 2017: Few Variations in Somatic Mutations Observed Between Pregnant and Non-Pregnant Patients with Breast Cancer Breast cancer - Cancer in Special Situations - Translational research
03 May 2017 FDA Grants Accelerated Approval to Durvalumab for Locally Advanced or Metastatic Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
03 May 2017 FDA Approves Midostaurin and a Companion Diagnostic Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy
02 May 2017 FDA Grants Accelerated Approval to Brigatinib and Breakthrough Therapy Designation to Lorlatinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
28 Apr 2017 FDA Expands Indications for Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Apr 2017 EMA Recommends Approval of Two Biosimilar Medicines – Biosimilar Rituximab Haematologic malignancies - Anticancer agents & Biologic therapy
26 Apr 2017 EMA Recommends Granting a Marketing Authorisation for Inotuzumab Ozogamicin Haematologic malignancies - Anticancer agents & Biologic therapy
25 Apr 2017 EMA Recommends Extension of Indications for Bevacizumab Gynaecologic malignancies - Anticancer agents & Biologic therapy
24 Apr 2017 EMA Recommends Extension of Indications for Nivolumab Genitourinary cancers - Cancer Immunology and Immunotherapy
19 Apr 2017 FDA Grants Atezolizumab Accelerated Approval as Initial Treatment for Certain Patients with Advanced Bladder Cancer Genitourinary cancers - Cancer Immunology and Immunotherapy
14 Apr 2017 FDA Allows Marketing of First Whole Slide Imaging System for Digital Pathology Pathology/Molecular biology